PHARMACIE BUYL

Elsene ·KBO/BCE: BE 0740.599.255

Loading dossier…

Year closed	Due by	Filed	Variance	Reference
31-12-2025	31-07-2026	02-06-2026	59 d early	2026-00138577
31-12-2024	31-07-2025	12-08-2025	12 d late	2025-00389403
31-12-2023	31-07-2024	04-07-2024	27 d early	2024-00232128
31-12-2022	31-07-2023	28-06-2023	33 d early	2023-00209307
31-12-2021	31-07-2022	30-05-2022	62 d early	2022-20046224
31-12-2020	31-07-2021	20-08-2021	20 d late	2021-50900176

Metric	This company	Sector median	Position in the sector
Solvency	3.9%	13.9%	better than 31% of 249 sector peers
Net result	€-24k	€19k	better than 29% of 249 sector peers
Equity	€38k	€95k	better than 35% of 249 sector peers
Gross operating margin	€377k	€323k	better than 57% of 218 sector peers
Staff costs	€291k	€281k	higher than 51% of 220 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€956k
Fixed assets	21/28	€478k
Intangible fixed assets	21	€153k
Tangible fixed assets	22/27	€325k
Current assets	29/58	€479k
Stocks & contracts in progress	3	€188k
Amounts receivable within one year	40/41	€105k
Cash & bank	54/58	€35k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€956k
Equity	10/15	€38k
Contributions / capital	10/11	€30k
Accumulated profits (losses)	14	€8k
Amounts payable	17/49	€919k
Amounts payable after one year	17	€442k
Amounts payable within one year	42/48	€477k
Trade debts payable within one year	44	€145k
Income statement
Gross operating margin	9900	€377k
Operating result	9901	€-14k
Financial income	75	€7k
Financial charges	65	€18k
Result before taxes	9903	€-24k
Income taxes	67/77	€351
Net result for the period	9904	€-24k
Result to be appropriated	9905	€-24k

Summary